Alpha 2.0
Login Register
» Articles » PMID: 37045710

Tirzepatide Decreases Systolic and Diastolic Blood Pressure

Overview
Journal Eur J Intern Med
Specialty General Medicine
Date 2023 Apr 12
PMID 37045710
Authors
Sidar Copur
Atalay Demiray
David Cherney
Katherine Tuttle
Mehmet Kanbay
Affiliations
Soon will be listed here.
Citing Articles

Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis.

Zeng Q, Xu J, Mu X, Shi Y, Fan H, Li S Front Endocrinol (Lausanne). 2023; 14:1214334.

PMID: 37908750 PMC: 10613702. DOI: 10.3389/fendo.2023.1214334.